Indonesia · Delayed Price · Currency is IDR IDX:MEDS Statistics
Total Valuation
IDX:MEDS has a market cap or net worth of IDR 117.19 billion. The enterprise value is 123.14 billion.
| Market Cap | 117.19B |
| Enterprise Value | 123.14B |
Important Dates
The next estimated earnings date is Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:MEDS has 1.56 billion shares outstanding.
| Current Share Class | 1.56B |
| Shares Outstanding | 1.56B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.70% |
| Owned by Institutions (%) | n/a |
| Float | 723.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.81 |
| PB Ratio | 2.41 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.18 |
| Quick Ratio | 0.31 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 25.11 |
| Debt / FCF | -1.67 |
| Interest Coverage | -5.54 |
Financial Efficiency
Return on equity (ROE) is -8.20% and return on invested capital (ROIC) is -7.32%.
| Return on Equity (ROE) | -8.20% |
| Return on Assets (ROA) | -3.89% |
| Return on Invested Capital (ROIC) | -7.32% |
| Return on Capital Employed (ROCE) | -8.09% |
| Weighted Average Cost of Capital (WACC) | 10.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 18 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.81 |
Taxes
| Income Tax | -221.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.89% in the last 52 weeks. The beta is 1.18, so IDX:MEDS's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +38.89% |
| 50-Day Moving Average | 74.04 |
| 200-Day Moving Average | 75.73 |
| Relative Strength Index (RSI) | 54.63 |
| Average Volume (20 Days) | 26,219,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDS had revenue of IDR 15.01 billion and -4.16 billion in losses. Loss per share was -2.66.
| Revenue | 15.01B |
| Gross Profit | 4.73B |
| Operating Income | -4.02B |
| Pretax Income | -4.38B |
| Net Income | -4.16B |
| EBITDA | -128.86M |
| EBIT | -4.02B |
| Loss Per Share | -2.66 |
Balance Sheet
The company has 252.69 million in cash and 6.21 billion in debt, with a net cash position of -5.95 billion or -3.81 per share.
| Cash & Cash Equivalents | 252.69M |
| Total Debt | 6.21B |
| Net Cash | -5.95B |
| Net Cash Per Share | -3.81 |
| Equity (Book Value) | 48.62B |
| Book Value Per Share | 31.12 |
| Working Capital | 2.85B |
Cash Flow
In the last 12 months, operating cash flow was -727.01 million and capital expenditures -3.00 billion, giving a free cash flow of -3.72 billion.
| Operating Cash Flow | -727.01M |
| Capital Expenditures | -3.00B |
| Depreciation & Amortization | 3.89B |
| Net Borrowing | -576.33M |
| Free Cash Flow | -3.72B |
| FCF Per Share | -2.38 |
Margins
Gross margin is 31.52%, with operating and profit margins of -26.81% and -27.68%.
| Gross Margin | 31.52% |
| Operating Margin | -26.81% |
| Pretax Margin | -29.16% |
| Profit Margin | -27.68% |
| EBITDA Margin | -0.86% |
| EBIT Margin | -26.81% |
| FCF Margin | n/a |
Dividends & Yields
IDX:MEDS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.55% |
| FCF Yield | -3.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:MEDS has an Altman Z-Score of 3.74 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.74 |
| Piotroski F-Score | 3 |